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The prevalence of cytomegalovirus (CMV) in HIV infected
patients is 90%. Both CMV and HIV are involved in the
pathogenesis of metabolic and cardiovascular diseases.
The study retrospectively evaluated the correlation of
CMV infection with lipodystrophy (LD) and hypertension
(HTA) in HIV patients who have been beneficiaries of
medical care in Galați, during 2013. The evolution of
anthropometric parameters, CDC-HIV categories, the
immunity by LyCD4, the category of detectable or unde-
tectable HIV-RNA, the categories high/low for values of
cholesterol, triglycerides, glucose, fibrinogen and for sero-
logical CMV-IgG (ELISA), were collected from the records
of 165 patients. CMV-IgG titers were converted in high or
low dichotomous variables, referring to the quartile (Q) 3.
Statistical analysis (XL-Stat) evaluated the correlations
between groups, with c2 test for dichotomous variables
and Student’s t test for continuous variables.
The characteristics of patients are: median age 25 years
[20;50]; men sex 53.7%; rural area 50.3%; low literacy
(<4 years) 25%; smokers 58%; co-infection with HBV
28.5%; median length of HIV diagnosis 12 years; AIDS
category 74%; current antiretroviral treatment 95%, with
average 2 [0;8] previous combinations; median nadir
LyCD4=144/cmm, median current LyCD4=507/cmm,
undetectable HIV-RNA (<400 copies/mL) 69%. The preva-
lence of positive CMV-IgG is 87% and 25.5% of the values
are over Q3. Hypertension was found in 9.7% and LD in
48% of patients, specifying 36% atrophy (LA), 6% hypertro-
phy (LH) and 6% mixed lipodystrophy (ML). High values
of CMV-IgG were associated with severe immunosuppres-
sion of nadir LyCD4 (p=0.002), high fibrinogen level
(p<0.001), HTA (p=0.032) and ML pattern (p<0.001).
There was no correlation of CMV-IgG with LA, LH,
HIV-RNA, cholesterol, triglycerides and glucose.
The levels of CMV-IgG should be monitored in HIV
patients as a risk factor for hypertension and mixed
lipodystrophy in order to allow early interventions for
management of these co-morbidities.
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